ALIVUSPharmaceuticals
Alivus Life Sciences Limited — Balance Sheet
₹980.80
-0.40%
Alivus Life Sciences Limited Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 12.25 Cr | 12.25 Cr | 12.25 Cr | 12.25 Cr | — |
| Share Issued | 12.25 Cr | 12.25 Cr | 12.25 Cr | 12.25 Cr | — |
| Total Debt | 56.61 Cr | 17.15 Cr | 19.36 Cr | 2.88 Cr | — |
| Tangible Book Value | 2.80K Cr | 2.32K Cr | 2.12K Cr | 2.04K Cr | — |
| Invested Capital | 2.82K Cr | 2.33K Cr | 2.14K Cr | 2.05K Cr | — |
| Working Capital | 1.86K Cr | 1.48K Cr | 1.35K Cr | 1.38K Cr | — |
| Net Tangible Assets | 2.80K Cr | 2.32K Cr | 2.12K Cr | 2.04K Cr | — |
| Capital Lease Obligations | 56.61 Cr | 17.15 Cr | 19.36 Cr | 2.88 Cr | — |
| Common Stock Equity | 2.82K Cr | 2.33K Cr | 2.14K Cr | 2.05K Cr | — |
| Total Capitalization | 2.82K Cr | 2.33K Cr | 2.14K Cr | 2.05K Cr | — |
| Total Equity Gross Minority Interest | 2.82K Cr | 2.33K Cr | 2.14K Cr | 2.05K Cr | — |
| Stockholders Equity | 2.82K Cr | 2.33K Cr | 2.14K Cr | 2.05K Cr | — |
| Other Equity Interest | 2.79K Cr | 11.06 Cr | 6.68 Cr | 3.50 Cr | — |
| Capital Stock | 24.51 Cr | 24.50 Cr | 24.50 Cr | 24.50 Cr | — |
| Common Stock | 24.51 Cr | 24.50 Cr | 24.50 Cr | 24.50 Cr | — |
| Total Liabilities Net Minority Interest | 594.08 Cr | 518.09 Cr | 563.94 Cr | 416.69 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 123.92 Cr | 79.32 Cr | 67.40 Cr | 32.70 Cr | — |
| Non Current Deferred Taxes Liabilities | 54.43 Cr | 48.78 Cr | 42.43 Cr | 31.50 Cr | — |
| Long Term Debt And Capital Lease Obligation | 50.96 Cr | 14.76 Cr | 17.09 Cr | 1.20 Cr | — |
| Long Term Capital Lease Obligation | 50.96 Cr | 14.76 Cr | 17.09 Cr | 1.20 Cr | — |
| Long Term Provisions | 18.54 Cr | 15.77 Cr | — | — | — |
| Current Liabilities | 470.16 Cr | 438.77 Cr | 496.54 Cr | 384.00 Cr | — |
| Other Current Liabilities | 16.63 Cr | 15.42 Cr | 29.68 Cr | 3.40 Cr | — |
| Current Debt And Capital Lease Obligation | 5.65 Cr | 2.39 Cr | 2.27 Cr | 1.68 Cr | — |
| Current Capital Lease Obligation | 5.65 Cr | 2.39 Cr | 2.27 Cr | 1.68 Cr | — |
| Current Provisions | 16.96 Cr | 12.03 Cr | 15.54 Cr | 14.44 Cr | — |
| Payables | 390.46 Cr | 419.09 Cr | 477.59 Cr | 339.13 Cr | — |
| Accounts Payable | 390.46 Cr | 368.66 Cr | 427.23 Cr | 324.40 Cr | — |
| Total Assets | 3.41K Cr | 2.85K Cr | 2.70K Cr | 2.47K Cr | — |
| Total Non Current Assets | 1.08K Cr | 934.41 Cr | 851.81 Cr | 706.42 Cr | — |
| Other Non Current Assets | 8.80 Cr | 10000.00 | 1.27 Cr | 14.07 Cr | — |
| Investmentin Financial Assets | 6.45 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr | — |
| Available For Sale Securities | 6.45 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr | — |
| Goodwill And Other Intangible Assets | 19.94 Cr | 14.85 Cr | 18.00 Cr | 10.38 Cr | — |
| Other Intangible Assets | 19.94 Cr | 14.85 Cr | 18.00 Cr | 10.38 Cr | — |
| Net PPE | 1.04K Cr | 904.78 Cr | 825.52 Cr | 690.41 Cr | — |
| Gross PPE | 1.04K Cr | 1.10K Cr | 977.14 Cr | 803.39 Cr | — |
| Construction In Progress | 94.25 Cr | 109.77 Cr | 50.63 Cr | 105.76 Cr | — |
| Other Properties | 942.67 Cr | 795.01 Cr | 774.89 Cr | 584.65 Cr | — |
| Current Assets | 2.34K Cr | 1.92K Cr | 1.85K Cr | 1.76K Cr | — |
| Other Current Assets | 102.75 Cr | 0.52 Cr | 0.64 Cr | 56.78 Cr | — |
| Inventory | 673.95 Cr | 666.59 Cr | 604.17 Cr | 516.24 Cr | — |
| Accounts Receivable | 969.74 Cr | 765.43 Cr | 806.77 Cr | 673.49 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 588.72 Cr | 301.41 Cr | 283.82 Cr | 517.30 Cr | — |
| Other Short Term Investments | 517.65 Cr | 90.55 Cr | 44.01 Cr | 5.15 Cr | — |
| Cash And Cash Equivalents | 71.06 Cr | 301.41 Cr | 283.82 Cr | 512.16 Cr | — |
| Retained Earnings | — | 1.29K Cr | 1.10K Cr | 1.02K Cr | 750.79 Cr |
| Additional Paid In Capital | — | 1.00K Cr | 1.00K Cr | 1.00K Cr | 0.00 |
| Non Current Pension And Other Postretirement Benefit Plans | — | 15.77 Cr | 7.87 Cr | — | — |
| Current Deferred Taxes Liabilities | — | 0.00 | 7.08 Cr | — | — |
| Pensionand Other Post Retirement Benefit Plans Current | — | 12.03 Cr | 7.67 Cr | — | 19.90 Cr |
| Other Payable | — | 50.25 Cr | 50.27 Cr | 2.72 Cr | 937.53 Cr |
| Dividends Payable | — | 0.18 Cr | 0.10 Cr | 70000.00 | 0.00 |
| Total Tax Payable | — | 0.00 | 7.08 Cr | 12.00 Cr | 13.69 Cr |
| Non Current Prepaid Assets | — | 14.70 Cr | 8.21 Cr | 5.56 Cr | 8.55 Cr |
| Accumulated Depreciation | — | -199.36 Cr | -151.62 Cr | -112.99 Cr | -77.28 Cr |
| Machinery Furniture Equipment | — | 627.33 Cr | 574.26 Cr | 442.64 Cr | 412.91 Cr |
| Buildings And Improvements | — | 339.61 Cr | 324.81 Cr | 227.56 Cr | 211.92 Cr |
| Land And Improvements | — | 27.44 Cr | 27.44 Cr | 27.44 Cr | 17.33 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.18 Cr | 25.57 Cr | 70000.00 | 0.00 |
| Prepaid Assets | — | 91.50 Cr | 58.42 Cr | 15.82 Cr | 19.02 Cr |
| Finished Goods | — | 69.68 Cr | 50.38 Cr | 26.44 Cr | 36.23 Cr |
| Work In Process | — | 408.26 Cr | 370.91 Cr | 310.45 Cr | 341.89 Cr |
| Raw Materials | — | 188.65 Cr | 182.88 Cr | 179.35 Cr | 135.30 Cr |
| Other Receivables | — | 90.37 Cr | 70.94 Cr | 22.56 Cr | 62.76 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.31 Cr | 0.00 | — | — |
| Gross Accounts Receivable | — | 765.74 Cr | 806.77 Cr | — | — |
| Cash Equivalents | — | 269.60 Cr | 228.06 Cr | 490.00 Cr | 0.00 |
| Cash Financial | — | 31.82 Cr | 55.76 Cr | 22.16 Cr | 115.60 Cr |
| Taxes Receivable | — | — | 27.60 Cr | 19.16 Cr | 44.59 Cr |
| Current Debt | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Alivus Life Sciences Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.